Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Fine

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Journal of Toxicology and Environmental Health|March 1, 1996
Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoproteinC L Lanning, R L Fine, C W Sachs, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitroS Hayashi, D W Norbeck, W Rosenbrook, et al.
Biochemical Pharmacology|January 1, 1987
Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathioneR F Ozols, K G Louie, J Plowman, et al.
Oncogene|May 4, 1995
Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumorsA T De Souza, G R Hankins, M K Washington, et al.
Cancer Chemotherapy and Pharmacology|June 15, 1999
Phase I and pharmacokinetic analysis of high-dose tamoxifen and chemotherapy in normal and tumor-bearing dogsJ R Waddle, R L Fine, B C Case, et al.
The Journal of Biological Chemistry|November 27, 1999
Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cellsA L Kim, A J Raffo, P W Brandt-Rauf, et al.
Hepato-Gastroenterology|February 10, 1999
Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinomaA L Cheng, K H Yeh, R L Fine, et al.
Annals of Surgery|August 1, 1995
Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinomaS R Sue, R S Chari, F M Kong, et al.
Journal of the National Cancer Institute|July 3, 1996
Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cellsC N Robertson, K M Roberson, G M Padilla, et al.
Biochemical Pharmacology|March 26, 1998
Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifenA L Cheng, S E Chuang, R L Fine, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Journal of Toxicology and Environmental Health|March 1, 1996
Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoproteinC L Lanning, R L Fine, C W Sachs, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1990
Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitroS Hayashi, D W Norbeck, W Rosenbrook, et al.
Biochemical Pharmacology|January 1, 1987
Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathioneR F Ozols, K G Louie, J Plowman, et al.
Oncogene|May 4, 1995
Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumorsA T De Souza, G R Hankins, M K Washington, et al.
Cancer Chemotherapy and Pharmacology|June 15, 1999
Phase I and pharmacokinetic analysis of high-dose tamoxifen and chemotherapy in normal and tumor-bearing dogsJ R Waddle, R L Fine, B C Case, et al.
The Journal of Biological Chemistry|November 27, 1999
Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cellsA L Kim, A J Raffo, P W Brandt-Rauf, et al.
Hepato-Gastroenterology|February 10, 1999
Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinomaA L Cheng, K H Yeh, R L Fine, et al.
Annals of Surgery|August 1, 1995
Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinomaS R Sue, R S Chari, F M Kong, et al.
Journal of the National Cancer Institute|July 3, 1996
Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cellsC N Robertson, K M Roberson, G M Padilla, et al.
Biochemical Pharmacology|March 26, 1998
Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifenA L Cheng, S E Chuang, R L Fine, et al.
Pageof 7